Live Courses

The annual Penn Neuromuscular Symposium will discuss available and novel therapies for patients with neuromuscular disorders ranging from immuno-modulation to gene therapy. Experts will also present clinical cases selected from the Penn neuromuscular clinic to discuss where new diagnostic methods and treatments apply. The course will be interactive and attendees are encouraged to participate and exchange their experience and ask questions as they see fit. The Symposium will also explain how to...

This course is designed to provide the audience with the most current clinical advances in ophthalmology and highlight on-going research taking place at the Scheie Eye Institute in the fields of glaucoma, anterior segment, retinal diseases, genetics, oculoplastic surgery, neuro-ophthalmology and ocular pathology. Evidence-based guidelines are an important foundational element to anchor a population health approach that advances eye and vision health. First, they provide guidance based on sound, ...

This symposium provides up-to-date content on topics relevant in today's primary care practice environment. Attendees engage with experts sharing latest information on common diseases/conditions/issues faced by PCPs, including screening, prevention, treatment and management.This is a Jointly Provided symposium between Thomas Jefferson University and Penn Medicine. Thomas Jefferson will process all registration payments and will also handle credits. For more information and to register, click the...

This is the 32nd year for the State of the Art Arrhythmia Symposium. Using a combination of case presentations with audience participation, didactic presentations, and question and answer sessions, our goal is to educate the participants in state of the art information on invasive and non-invasive electrophysiologic and electrocardiographic tools used in the current diagnosis, evaluation and treatment of cardiac rhythm disorders. The program is taught by members of the faculty and staff from the...

Glomerular disease is associated with morbidity and mortality in patients of all ages and is a common cause of end stage kidney disease. These include those that commonly present with nephrotic syndrome (minimal change disease, FSGS and membranous nephropathy), the nephritic syndrome (vasculitis, lupus nephritis and IgA nephropathy), among others. Treatment often utilizes immunosuppressive regimens such as high dose corticosteroids, alkylating agents, calcineurin inhibitors, biologics and anti...

CVD is the leading cause of death in the US. Hypertension and diabetes are among the foremost risk factors for the development of CVD, stroke, peripheral artery disease, and heart attack. This program will provide an overview of recent advances that target the underlying pathophysiology of cardiovascular disease. The focus of the program will be on the new therapeutic strategies for hypertension, hyperlipidemia, and CKD.